Alpine Associates Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Alpine Associates Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,790,400	Closed	-$37.5M	–	81
2016 Q3	$37.5M	Buy	+1,790,400	New	+$20.6M	1.37%	27

Alpine Associates Management's VTAE Position: Q4 2016 in Review

Alpine Associates Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,790,400 shares — an estimated $37.5M sold.

Alpine Associates Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $37.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Alpine Associates Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Alpine Associates Management sold 1,790,400 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $37.5M.
Alpine Associates Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Alpine Associates Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $37.5M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Alpine Associates Management's 13F filing for Q4 2016, filed 13 Feb 2017.